The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...
The drug is not considered a cure, but results from clinical trials point to major advancement for a devastating cancer ...
Foresee Pharmaceuticals has shown that a long-acting version of its injectable prostate cancer med Camcevi can help patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback